Blog

Why antibodies transformed immunotherapy: ADCC and CDC, checkpoint blockade, and T‑cell engagement, plus where combinations are headed against resistant tumors.

How ELISA kits achieve specific, reliable readouts: key components, curve fitting, common pitfalls, and QC practices that keep results trustworthy across studies.

Explore the top 10 FDA-approved antibody drugs in 2023, including Humira, Keytruda, and Rituxan, and learn how Biointron supports antibody drug discovery and development.

Learn how antibody screening works, including key methods like ELISA and flow cytometry, and why it is essential for developing drugs, vaccines, and diagnostic applications.

VHH combine small size with big performance—excellent stability, deep tissue access, and easy formatting—making them powerful tools for research and therapy.

Explore the history of antibody research, from Emil von Behring’s diphtheria breakthroughs to hybridoma technology and modern advances in recombinant antibody development.

Recombinant antibodies deliver speed, consistency, and custom design. Learn how they are engineered, validated, and scaled to out‑perform traditional hybridoma tools.

What an antibody is and why it matters: structure, function, and the roles antibodies play across diagnostics and therapy, explained for fast, confident understanding.

Compare delivery options for antibody‑based therapies—conjugates, nanoparticles, liposomes, and long‑acting platforms—to improve exposure, precision, and patient safety.

Explore next‑generation antibody formats—bispecifics, trispecifics, and modular designs—that unlock new mechanisms, sharpen targeting, and raise the bar for developability.

Learn about monoclonal, polyclonal, and recombinant antibodies, including their production methods, defining characteristics, and roles in research and therapy.

Explore the top FDA-approved antibody drugs from 1980-2022, including Humira, Keytruda, and Herceptin, their development history, and uses in cancer and autoimmune diseases.